Li et al. found that HMGB1 is transported from the nuclei to the cytoplasm and extracellular space via autophagic vacuoles, following treatment with TMZ, and GBM patients with high levels of HMGB1 in the intracellular region always have a worse prognosis. This evidence concerns the gene HMGB1 and glioblastoma.